More than 12% of American adults are now taking a GLP-1 medication — a number that more than doubled in the past eighteen months alone. These drugs are genuinely, historically remarkable. Semaglutide produces roughly 15% total body weight loss in clinical trials. Tirzepatide pushes that to nearly 21%. For millions of people who have struggled with obesity for decades, that is life-changing. The cardiovascular benefits, the metabolic reset, the relief from joint pain, the restored energy — this is real medicine doing real things.

But there is a downstream consequence that the prescribing community — primary care, endocrinology, obesity medicine — is not consistently preparing patients for. When you lose 50, 60, 80 pounds in under a year, your skin doesn't know what happened. Your face doesn't know what happened. Your breasts don't know. And the aesthetic consequences — Ozempic face, skin laxity, deflated body contours, muscle loss — are landing patients in plastic surgery consult rooms faster than the field can adapt.

In this episode, Dr. Chris Lee and Jenna Gomez take a firmly pro-GLP-1 stance while giving patients the full picture: what these drugs actually do, why the aesthetic side effects happen, what can be done about them, and — critically — what patients should be doing from day one to protect themselves.

Episode Overview

1: What GLP-1s actually do and why they work so well

2: Ozempic face — the mechanism, the reality, and the fix

3: The body: skin laxity, muscle loss, and breast deflation

4: The surgical wave — what procedures are surging and why

5: Chris's honest take — should you be on one?

The med spa industry is a $19 billion market in the United States alone — and it is almost entirely unregulated at the federal level. There is no single governing body overseeing who is holding a syringe in the procedure room. Rules vary wildly by state, enforcement is inconsistent, and patients routinely walk in without any idea who is actually qualified to touch their face — or whether the product in that syringe is even real.

In this episode, Dr. Chris Lee is joined by Jenna Gomez — patient coordinator at Clareo Aesthetics, trusted colleague, and the person who talks to patients every single day about what they've had done, what went wrong, and what they wish they'd known. Together they break down who is legally allowed to inject, what a weekend certification course actually teaches (and doesn't), how to tell a legitimate practice from a liability waiting to happen, and what Jenna sees patients consistently getting wrong before they ever walk through the door.

There's also a local angle that hits close to home: in late 2025, a Massachusetts man pleaded guilty to injecting patients with unapproved botulinum toxin at his Milton med spa, leading to ten documented botulism cases. This isn't a Florida problem. It's a right-here, right-now problem.

The aesthetic industry performs over 38 million procedures globally per year — and a growing share of patients are coming to their first consultation not asking 'can you help me look better?' but 'can you fix what someone else did to me?' This episode tackles the uncomfortable truth at the heart of modern aesthetic medicine: the problem isn't just bad surgeons. It's an industry that has normalized the over-operated look, confused patients who can't distinguish between a good result and a famous one, and a filler culture running completely out of control.

Dr. Lee gives his honest, unfiltered take — backed by real statistics and real consult-room experience — on what separates a natural, beautiful result from one that screams 'I've had work done.' He covers the pillow-face filler epidemic, the windswept facelift problem, what a natural result actually looks like, and the exact questions patients should ask before trusting anyone with their face.